New 3-Amino-2-Thioxothiazolidin-4-One-Based Inhibitors of Acetyl- and Butyryl-Cholinesterase: Synthesis and Activity

References

• Mousavi SM , Zarei M , Hashemi SA , Babapoor A , Amani AM . A conceptual review of rhodanine: current applications of antiviral drugs, anticancer and antimicrobial activities. Artif. Cells Nanomed. Biotechnol. 47, 1132–1148 (2019).
   PubMed Web of Science ®Google Scholar
• Kaminskyy D , Kryshchyshyn A , Lesyk R . 5-Ene-4-thiazolidinones: an efficient tool in medicinal chemistry. Eur. J. Med. Chem. 140, 542–594 (2017).
   PubMed Web of Science ®Google Scholar
• Krátký M , Štěpánková Š , Vorčáková K , Vinšová J . Synthesis and in vitro evaluation of novel rhodanine derivatives as potential cholinesterase inhibitors. Bioorg. Chem. 68, 23–29 (2016).
   PubMed Web of Science ®Google Scholar
• Krátký M , Sramel P , Bodo P et al. Novel rhodanine based inhibitors of aldose reductase of non-acidic nature with p-hydroxybenzylidene functional group. Eur. J. Med. Chem. 246, 114922 (2023).
   PubMed Web of Science ®Google Scholar
• Mendgen T , Steuer C , Klein CD . Privileged scaffolds or promiscuous binders: a comparative study on rhodanines and related heterocycles in medicinal chemistry. J. Med. Chem. 55, 743–753 (2012).
   PubMed Web of Science ®Google Scholar
• Tomašić T , Mašić LP . Rhodanine as a scaffold in drug discovery: a critical review of its biological activities and mechanisms of target modulation. Expert Opin. Drug Discov. 7, 549–560 (2012).
   PubMed Web of Science ®Google Scholar
• Arsovska E , Trontelj J , Zidar N et al. Evaluation of Michael-type acceptor reactivity of 5-benzylidenebarbiturates, 5-benzylidenerhodanines, and related heterocycles using NMR. Acta Chim. Slov. 61, 637–644 (2014).
   PubMed Web of Science ®Google Scholar
• Kaminskyy D , Kryshchyshyn A , Lesyk R . Recent developments with rhodanine as a scaffold for drug discovery. Expert Opin. Drug Discov. 12, 1233–1252 (2017).
   PubMed Web of Science ®Google Scholar
• Krátký M , Vu QA , Štěpánková Š et al. Novel propargylamine-based inhibitors of cholinesterases and monoamine oxidases: synthesis, biological evaluation and docking study. Bioorg. Chem. 116, 105301 (2021).
   PubMed Web of Science ®Google Scholar
• Brem J , van Berkel SS , Aik W et al. Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition. Nat. Chem. 6, 1084–1090 (2014).
   PubMed Web of Science ®Google Scholar
• Čolović MB , Krstić DZ , Lazarević-Pašti TD , Bondžić AM , Vasić VM . Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr. Neuropharmacol. 11, 315–335 (2013).
   PubMed Web of Science ®Google Scholar
• Swetha R , Kumar D , Gupta SK et al. Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer’s disease. Future Med. Chem. 11(24), 3161–3178 (2019).
   PubMed Web of Science ®Google Scholar
• Hameed S , Babatunde O , Salar U et al. Efficient one-pot synthesis of arylated pyrazole-fused pyran analogs: as leads to treating diabetes and Alzheimer’s disease. Future Med. Chem. 14(21), 1507–1526 (2022).
   PubMed Web of Science ®Google Scholar
• Smyrska-Wieleba N , Mroczek T . Natural inhibitors of cholinesterases: chemistry, structure–activity and methods of their analysis. Int. J. Mol. Sci. 24(3), 2722 (2023).
   PubMed Web of Science ®Google Scholar
• Zhou S , Huang G . The biological activities of butyrylcholinesterase inhibitors. Biomed. Pharmacother. 146, 112556 (2022).
   PubMed Web of Science ®Google Scholar
• Obaid RJ , Naeem N , Mughal EU et al. Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase. RSC Adv. 12, 19764–19855 (2022).
   PubMed Web of Science ®Google Scholar
• Shafii N , Khoobi M , Amini M et al. Synthesis and biological evaluation of 5-benzylidenerhodanine-3-acetic acid derivatives as AChE and 15-LOX inhibitors. J. Enzyme Inhib. Med. Chem. 30, 389–395 (2015).
   PubMed Web of Science ®Google Scholar
• Bayindir S , Caglayan C , Karaman M , Gülcin İ . The green synthesis and molecular docking of novel N-substituted rhodanines as effective inhibitors for carbonic anhydrase and acetylcholinesterase enzymes. Bioorg. Chem. 90, 103096 (2019).
   PubMed Web of Science ®Google Scholar
• Krátký M , Štěpánková Š , Brablíková M , Svrčková K , Švarcová M , Vinšová J . Novel iodinated hydrazide-hydrazones and their analogues as acetyl- and butyrylcholinesterase inhibitors. Curr. Top. Med. Chem. 20, 2106–2117 (2020).
   PubMed Web of Science ®Google Scholar
• Krátký M , Svrčková K , Vu QA , Štěpánková Š , Vinšová J . Hydrazones of 4-(trifluoromethyl)benzohydrazide as new inhibitors of acetyl- and butyrylcholinesterase. Molecules 26, 989 (2021).
   PubMed Web of Science ®Google Scholar
• Yılmaz S , Akbaba Y , Özgeriş B et al. Synthesis and inhibitory properties of some carbamates on carbonic anhydrase and acetylcholine esterase. J. Enzyme Inhib. Med. Chem. 31, 1484–1491 (2016).
   PubMed Web of Science ®Google Scholar
• Karaman M , Temel Y , Bayindir S . Inhibition effect of rhodanines containing benzene moieties on pentose phosphate pathway enzymes and molecular docking. J. Mol. Struct. 1220, 128700 (2020).
   Web of Science ®Google Scholar
• Nederlof A . The preparation and reactions of some rhodanines. Recl. Trav. Chim. Pays-Bas 82, 75–89 (1963).
   Google Scholar
• Tabatabaee M , Heravi MM , Sharif M , Esfandiyari F . Fast and efficient method for imination of N-aminorhodanine using inorganic solid support under microwave irradiation and classical heating. E-J. Chem. 8, 535–540 (2011).
   Google Scholar
• Turkevich NM , Petlichnaya LI . UV absorption spectra of 3-aminorhodanine derivatives. Chem. Heterocycl. Compd. 7, 1111–1113 (1971).
   Google Scholar
• Powers JP , Piper DE , Li Y et al. SAR and mode of action of novel non-nucleoside inhibitors of hepatitis C NS5b RNA polymerase. J. Med. Chem. 49, 1034–1046 (2006).
   PubMed Web of Science ®Google Scholar
• Zdrazilova P , Stepankova S , Komers K , Ventura K , Cegan A . Half-inhibition concentrations of new cholinesterase inhibitors. Z. Naturforsch. C 59, 293–296 (2004).
   PubMedGoogle Scholar
• Lineweaver H , Burk D . The determination of enzyme dissociation constants. J. Am. Chem. Soc. 56, 658–666 (1934).
   Web of Science ®Google Scholar
• Pettersen EF , Goddard TD , Huang CC et al. UCSF Chimera – a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605–1612 (2004).
   PubMed Web of Science ®Google Scholar
• Trott O , Olson AJ . AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 31, 455–461 (2010).
   PubMed Web of Science ®Google Scholar
• Morris GM , Huey R , Lindstrom W et al. Autodock4 and AutoDockTools4: automated docking with selective receptor flexibility. J. Comput. Chem. 30, 2785–2791 (2009).
   PubMed Web of Science ®Google Scholar
• Park S , Lee H , Yi Y , Lim MH , Kim C . A rhodanine-based fluorescent chemosensor for sensing Zn2+ and Cd2+: applications to water sample and cell imaging. Inorganica Chim. Acta 513, 119936 (2020).
   Web of Science ®Google Scholar
• Sinko G , Calic M , Bosak A , Kovarik Z . Limitation of the Ellman method: cholinesterase activity measurement in the presence of oximes. Anal. Biochem. 370, 223–227 (2007).
   PubMed Web of Science ®Google Scholar
• Kandiah N , Pai M , Senanarong V et al. Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia. Clin. Interv. Aging 12, 697–707 (2017).
   PubMed Web of Science ®Google Scholar
• Ryan AJ , Gray NM , Lowe PN , Chung C . Effect of detergent on “promiscuous” inhibitors. J. Med. Chem. 46, 3448–3451 (2003).
   PubMed Web of Science ®Google Scholar
• Dvir H , Silman I , Harel M , Rosenberry TL , Sussman JL . Acetylcholinesterase: from 3D structure to function. Chem. Biol. Interact. 187, 10–22 (2010).
   PubMed Web of Science ®Google Scholar
• Ordentlich A , Barak D , Kronman C et al. Contribution of aromatic moieties of tyrosine 133 and of the anionic subsite tryptophan 86 to catalytic efficiency and allosteric modulation of acetylcholinesterase. J. Biol. Chem. 270, 2082–2091 (1995).
   PubMed Web of Science ®Google Scholar
• Kryger G , Silman I , Sussman JL . Structure of acetylcholinesterase complexed with E2020 (Aricept®): implications for the design of new anti-Alzheimer drugs. Structure 7, 297–307 (1999).
   PubMed Web of Science ®Google Scholar
• Silva LB , Ferreira EFB , Maryam et al. Galantamine based novel acetylcholinesterase enzyme inhibitors: a molecular modeling design approach. Molecules 28, 1035 (2023).
   PubMedGoogle Scholar
• Nicolet Y , Lockridge O , Masson P , Fontecilla-Camps JC , Nachon F . Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products. J. Biol. Chem. 278, 41141–41147 (2003).
   PubMed Web of Science ®Google Scholar